52.20 USD
↘ 4.50 (7.94%)AT CLOSE (11:59 AM EDT)
Exelixis Inc
EXELNASDAQ • USD
52.35
↗ 0.15 (0.29%)
POST MARKET (AS OF 07:57 PM EDT)
Post Market
AS OF 07:57 PM EDT
52.35
↗ 0.15 (0.29%)
Market: CLOSED
Exelixis Inc (EXEL) trades at $52.23 per share. EXEL shows a split signal: underlying fundamentals suggest "Buy" while technical indicators indicate "Sell". Notable factors include a robust Altman Z-Score, exceptional Return on Equity (43.0%) and a bullish Golden Cross on the moving averages. Valuation metrics place EXEL at a fair price relative to peers.
Technical & fundamental data as of Aug 6, 2026.
Open?$52.92
High?$55.44
Low?$51.76
Prev. Close?$56.70
Volume?5.4M
Avg. Volume?2.6M
VWAP?$53.34
Rel. Volume?2.04x
Bid / Ask
Bid?$51.50 × 100
Ask?$53.20 × 500
Spread?$1.70
Midpoint?$52.35
Valuation & Ratios
Market Cap?14.3B
Shares Out?251.4M
Float?243.5M
Float %?96.9%
P/E Ratio?17.10
P/B Ratio?7.36
EPS?$3.32
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
Employees
1.1K
Market Cap
14.3B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2000-04-11
Address
1851 HARBOR BAY PARKWAY
ALAMEDA, CA 94502
Phone: (650) 837-7000
ALAMEDA, CA 94502
Phone: (650) 837-7000
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?100
Momentum?94
Short Sent.?23
Piotroski F-Score?5/9Mixed
Altman Z-Score?15.38Safe
Confidence?59%Low
Short InterestVery High
Short % of Float?12.69%High
Short Interest?30.9M
Days to Cover?12.7
Free Float243.5M
Avg Daily Volume2.4M
Settlement Date2026-07-15
Financial Health
Current Ratio?3.26Strong
Quick Ratio?3.19Strong
Cash Ratio?0.61Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score78/100
P/E?17.1CHEAP▾
Peers100
S&P75
P/B?7.36FAIR▾
Peers100
S&P25
P/S?6.00FAIR▾
Peers100
S&P22
P/FCF?15.6CHEAP▾
Peers100
S&P72
EV/EBITDA?14.2FAIR▾
Peers100
S&P55
EV/Sales?5.90FAIR▾
Peers100
S&P29
Returns & Efficiency
ROE?43.1%STRONG▾
Peers50
S&P90
ROA?32.1%STRONG▾
Peers50
S&P97
Cash Flow & Enterprise
FCF?$912.2M
Enterprise Value?$14.0B
Fundamentals ratios updated end of day